Idiopathic chronic urticaria and thyroid autoimmunity: Experience of a single center

von Nuzzo, Vincenzo, Tauchmanova, Libuse, Colasanti, Paola, Zuccoli, Alfonso, Colao, Annamaria
Veröffentlicht 2011

SAT-443 Osilodrostat Has No Clinically Relevant Effect on the Pharmacokinetic (PK) Profile of a Monophasic Oral Contraceptive in Healthy Females Receiving Cortisol Replacement Ther...

von Breitschaft, Astrid, Tauchmanova, Libuse, Han, Kevin, Atkinson, Susan, Nauwelaerts, Heidi, Sengupta, Tirtha, Zic, Ivanka, Burgmeyer, Lisa, Pedroncelli, Alberto
Veröffentlicht in J Endocr Soc (2019)

MON-445 Long-Term Results of an Ongoing Non-Interventional, Real-World Observational Study of Pasireotide SC in Cushing's Disease

von Yuen, Kevin, Giordano, Carla, Deutschbein, Timo, Manetti, Luca, Roughton, Michael, Kriemler-Krahn, Ulrike, Tauchmanova, Libuse, Maamari, Ricardo, Schopohl, Jochen
Veröffentlicht in J Endocr Soc (2019)

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells

von Orio, Francesco, Muscogiuri, Giovanna, Palomba, Stefano, Serio, Bianca, Sessa, Mariarosaria, Giudice, Valentina, Ferrara, Idalucia, Tauchmanovà, Libuse, Colao, Annamaria, Selleri, Carmine
Veröffentlicht 2014

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

von Manetti, Luca, Deutschbein, Timo, Schopohl, Jochen, Yuen, Kevin C. J., Roughton, Michael, Kriemler-Krahn, Ulrike, Tauchmanova, Libuse, Maamari, Ricardo, Giordano, Carla
Veröffentlicht in Pituitary (2019)

Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease

von Newell-Price, John, Pivonello, Rosario, Tabarin, Antoine, Fleseriu, Maria, Witek, Przemysław, Gadelha, Mônica R, Petersenn, Stephan, Tauchmanova, Libuse, Ravichandran, Shoba, Gupta, Pritam, Lacroix, André, Biller, Beverly M K
Veröffentlicht in Eur J Endocrinol (2019)

Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study

von Fleseriu, Maria, Petersenn, Stephan, Biller, Beverly M. K., Kadioglu, Pinar, De Block, Christophe, T'Sjoen, Guy, Vantyghem, Marie‐Christine, Tauchmanova, Libuse, Wojna, Judi, Roughton, Michael, Lacroix, André, Newell‐Price, John
Veröffentlicht in Clin Endocrinol (Oxf) (2019)

OR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results from a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3)

von Biller, Beverly MK, Newell-Price, John, Fleseriu, Maria, Bertagna, Xavier, Findling, James, Shimatsu, Akira, Lee, Eun Jig, Gu, Feng, Auchus, Richard, Leelawattana, Rattana, Lacroix, André, Kim, Jung Hee, Laplanche, Audrey, O'Connell, Paul, Tauchmanova, Libuse, Pedroncelli, Alberto, Pivonello, Rosario
Veröffentlicht in J Endocr Soc (2019)